Sequential treatment of giant basal cell carcinomas

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 62, Issue 10, 2009, Pages

  Madan, V ^a,b   West, C A ^c   Murphy, J V ^c   Lear, J T ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Basal cell carcinoma; Giant basal cell carcinoma; Imiquimod; Metvix; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; IMIQUIMOD;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BREAST LESION; CANCER SIZE; CANCER SURGERY; CASE REPORT; CAUCASIAN; CELL INFILTRATION; CHRONIC INFLAMMATION; CLINICAL PROTOCOL; DELTOID MUSCLE; DISEASE DURATION; ERYTHEMA; EXCISION; FEMALE; FOLLOW UP; GIANT CELL TUMOR; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; PHOTODYNAMIC THERAPY; PLASTIC SURGERY; PRIORITY JOURNAL; PUNCH BIOPSY; SCALP; SKIN BIOPSY; SKIN FIBROSIS; SKIN TRANSPOSITION FLAP; SPLIT THICKNESS SKIN GRAFT; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; AGED; AMINOLEVULINIC ACID; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 70149105357     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2007.12.076     Document Type: Article

References (22)

1. Randle H.W., Roenigk R.K., and Brodland D.G. Giant basal cell carcinoma (T3): who is at risk?. Cancer 72 (1993) 1624-1630
2. Betti R., Inselvini E., Moneghini L., et al. Giant basal cell carcinomas: report of four cases and considerations. J Dermatol 24 (1997) 317-321
3. Manstein C.H., Gottlieb N., Manstein M.E., et al. Giant basal cell carcinoma: a series of seven T3 tumors without metastasis. Plast Reconstr Surg 106 (2000) 653-656
4. Kokavec R., and Fedeles J. Giant basal cell carcinomas: a result of neglect?. Acta Chir Plast 46 (2004) 67-69
5. Lackey P.L., Sargent L.A., Wong L., et al. Giant basal cell carcinoma surgical management and reconstructive challenges. Ann Plast Surg 58 (2007) 250-254
6. Rossi R., Campolmi P., Giomi B., et al. Giant exophytic basal cell carcinoma treated with radiotherapy. J Eur Acad Dermatol Venereol 16 (2002) 374-376
7. Radio-Sahl W.J. Giant basal cell carcinoma. Int J Dermatol 35 (1996) 222-223
8. Caloglu M., Yurut-Caloglu V., Kocak Z., et al. Metastatic giant basal cell carcinoma and radiotherapy. J Plast Reconstr Aesthet Surg 59 (2006) 783-784
9. Beutner K.R., Geisse J.R., Helman D., et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 41 (1999) 1002-1007
10. Marks R., Gebauer K., Shumack S., et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma:results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 44 (2001) 807-813
11. Bianchi L., Costanzo A., Campione E., et al. Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients. Clin Exp Dermatol 28 (2003) 24-26
12. Morton C.A., Whitehurst C., McColl J.H., et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 137 (2001) 319-324
13. Vinciullo C., Elliott T., Francis D., et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 152 (2005) 765-772
14. Cox N.H., and Dyson P. Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant skin lesions. Br J Dermatol 133 (1995) 60-65
15. Unlü R.E., Orbay H., Uysal A.C., et al. Unusual and giant tumors of head and neck region. J Craniofac Surg 17 (2006) 1219-1229
16. Madan V., and Lear J.T. Non surgical treatment options for non-melanoma skin cancers. Expert Rev Dermatol 2 (2007) 59-67
17. Horn M., Wolf P., Wulf H.C., et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 149 (2003) 1242-1249
18. Rhodes L.E., de Rie M., Enstrom Y., et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140 (2004) 17-23
19. Kuijpers D.I.M., Smeets N.W.J., Krekels G.A.M., et al. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 30 (2004) 794-798
20. Caekelbergh K., Annemans L., Lambert J., et al. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma. Br J Dermatol 155 (2006) 784-790
21. Chen T.M., Rosen T., Orengo I., et al. Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Dermatol Surg 28 (2002) 344-346
22. Kagy M.K., and Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg 26 (2000) 577-578